After the planned merger with Alcon, a new ophthalmology division will emerge in 2011 called Alcon. |
Since 2008, he is an independent consultant and member of several company boards of directors, including Alcon. |
Novartis reached an agreement in April 2008 with Nestlé S. A. providing the right to acquire majority ownership of Alcon Inc. |
The merger requires approval by the Boards of Directors of Novartis and Alcon. |
Following completion of the merger, Alcon will become the new eye care division of Novartis, including CIBA Vision and ophthalmic medicines. |
Novartis has said it wants to simplify the ownership structure and is offering 2.8 Novartis shares for every outstanding Alcon share. |